COMP <GO>
UNH vs LLY // 10Y YIELD & FRED MACRO BETA
UnitedHealth Group Incorporated (NYSE) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: UNH 6
— LLY 9
▲ 10Y YIELD & FRED MACRO BETA LEADER: LLY
LAST: $406.97 (-0.96%) • MKT CAP: $365.65B
macro-sensitivity
0.33
LAST: $1,417.54 (+3.19%) • MKT CAP: $1.34T
macro-sensitivity
0.51
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (UNH VS. LLY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | UNH | LLY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 88.57% | 83.64% | +4.93 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.47% | 32.36% | -20.89 | LLY | /roic <GO> |
| EV/EBITDA & P/E Valuation | 16.5x | 36.6x | -20.09 | UNH | /valuation <GO> |
| Free Cash Flow Yield | 6.46% | 2.29% | +4.17 | UNH | /fcf-yield <GO> |
| Operating Margin | 4.82% | 40.21% | -35.39 | LLY | /operating-margins <GO> |
| Net Profit Margin | 3.14% | 31.90% | -28.76 | LLY | /net-margins <GO> |
| Revenue Growth (YoY) | 6.46% | 45.51% | -39.05 | LLY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.28% | 0.49% | +1.79 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.12 | 9.33 | -6.21 | LLY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 9/9 | -2.00 | LLY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.74% | 6.77% | -0.03 | UNH | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.0 | 77.9 | -21.83 | LLY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 0.33 | 0.51 | -0.18 | LLY | /macro-sensitivity <GO> |
| Forward P/E Multiple | 17.1x | 26.3x | -9.16 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $365.65B | $1.34T | -$974.84B | LLY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | UNH REV | LLY REV | UNH GROSS % | LLY GROSS % | UNH FCF | LLY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $447.57B | $65.18B | 88.7% | 83.0% | $16.07B | $16.81B |
| FY 2024 | $400.28B | $45.04B | 88.3% | 81.3% | $20.70B | $8.82B |
| FY 2023 | $371.62B | $34.12B | 89.6% | 79.3% | $25.68B | $4.24B |
| FY 2022 | $324.16B | $28.54B | 89.6% | 76.8% | $23.40B | $7.59B |
| FY 2021 | $287.60B | $28.32B | 89.2% | 74.2% | $19.89B | $7.37B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
UNH // BETA 0.33
LLY // BETA 0.51